Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Abraham

Showing results (481-490 of 509) with videos related to

Pageof 51
Sort By:
Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.
EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epitheliumCarly G K Ziegler, Anna H Owings, Vincent N Miao, et al.
Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.
Nature Biotechnology|January 14, 2000
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vectorT Tamura, C Thibert, C Royer, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Cell|August 5, 2021
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19Carly G K Ziegler, Vincent N Miao, Anna H Owings, et al.
Developmental Cell|December 4, 2024
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19Carly G K Ziegler, Vincent N Miao, Anna H Owings, et al.
Microbiology Spectrum|April 30, 2024
An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfectionCarly G K Ziegler, Anna H Owings, Michelle Galeas-Pena, et al.
Pageof 51

Showing results (481-490 of 509) with videos related to

Sort By:
Pageof 51
Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.
EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epitheliumCarly G K Ziegler, Anna H Owings, Vincent N Miao, et al.
Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.
Nature Biotechnology|January 14, 2000
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vectorT Tamura, C Thibert, C Royer, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Cell|August 5, 2021
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19Carly G K Ziegler, Vincent N Miao, Anna H Owings, et al.
Developmental Cell|December 4, 2024
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19Carly G K Ziegler, Vincent N Miao, Anna H Owings, et al.
Microbiology Spectrum|April 30, 2024
An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfectionCarly G K Ziegler, Anna H Owings, Michelle Galeas-Pena, et al.
Pageof 51